drugset / Trial / NCT06932107
Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The goal of this Interventional study is to evaluate the efficacy and safety of Aprepitant Injection(QLG2174) for preventing PONV in Chinese patients.
Timeline
- Start
- 2024-02-02
- Primary completion
- 2024-05-28
- Completion
- 2024-06-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | 32 mg | Intravenous |
Indications
No indication recorded.